EP3295948 - USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF POTASSIUM ION CHANNEL MODULATOR MEDICINE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.12.2021 Database last updated on 24.01.2025 | |
Former | Examination is in progress Status updated on 04.09.2020 | ||
Former | Request for examination was made Status updated on 16.02.2018 | ||
Former | The international publication has been made Status updated on 18.11.2016 | Most recent event Tooltip | 03.12.2021 | Application deemed to be withdrawn | published on 05.01.2022 [2022/01] | Applicant(s) | For all designated states Shaanxi Momentum Pharmaceutical Co., Ltd. No. 1 Hancangnan Road Hi-tech District Xianyang, Shaanxi 712000 / CN | [2018/12] | Inventor(s) | 01 /
WANG, Baoan No. 1 Hancangnan Road Hi-tech District Xianyang Shaanxi 712000 / CN | 02 /
MAO, Peng No. 1 Hancangnan Road Hi-tech District Xianyang Shaanxi 712000 / CN | [2018/12] | Representative(s) | Keil & Schaafhausen Patentanwälte PartGmbB Bockenheimer Landstraße 25 60325 Frankfurt am Main / DE | [N/P] |
Former [2018/12] | Keil & Schaafhausen Patent- und Rechtsanwälte PartGmbB Friedrichstrasse 2-6 60323 Frankfurt am Main / DE | Application number, filing date | 16792197.2 | 12.05.2016 | [2018/12] | WO2016CN81796 | Priority number, date | CN201510243075 | 13.05.2015 Original published format: CN201510243075 | [2018/12] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016180347 | Date: | 17.11.2016 | Language: | ZH | [2016/46] | Type: | A1 Application with search report | No.: | EP3295948 | Date: | 21.03.2018 | Language: | EN | [2018/12] | Search report(s) | International search report - published on: | CN | 17.11.2016 | (Supplementary) European search report - dispatched on: | EP | 22.11.2018 | Classification | IPC: | A61K36/8968, A61P9/06 | [2018/12] | CPC: |
A61K36/8968 (EP,US);
A61K36/718 (KR);
A61K36/076 (KR,US);
A61K36/185 (US);
A61K36/258 (KR,US);
A61K36/282 (KR,US);
A61K36/484 (US);
A61K36/489 (KR,US);
A61K36/62 (KR);
A61K36/736 (US);
A61K36/75 (KR);
A61K36/752 (US);
A61K36/8888 (KR,US);
A61P9/06 (KR,US);
A61K2236/00 (US);
A61K2300/00 (KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/12] | Title | German: | VERWENDUNG EINER ZUSAMMENSETZUNG NACH ART DER TRADITIONELLEN CHINESISCHEN MEDIZIN BEI DER HERSTELLUNG VON PHARMAZEUTISCHEN KALIUMIONENKANALMODULATOREN | [2018/12] | English: | USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF POTASSIUM ION CHANNEL MODULATOR MEDICINE | [2018/12] | French: | UTILISATION D'UNE COMPOSITION DE MÉDECINE TRADITIONNELLE CHINOISE DANS LA PRÉPARATION D'UN MÉDICAMENT MODULATEUR DES CANAUX POTASSIQUES | [2018/12] | Entry into regional phase | 23.11.2017 | Translation filed | 23.11.2017 | National basic fee paid | 23.11.2017 | Search fee paid | 23.11.2017 | Designation fee(s) paid | 23.11.2017 | Examination fee paid | Examination procedure | 23.11.2017 | Examination requested [2018/12] | 23.11.2017 | Date on which the examining division has become responsible | 14.06.2019 | Amendment by applicant (claims and/or description) | 07.09.2020 | Despatch of a communication from the examining division (Time limit: M04) | 15.01.2021 | Reply to a communication from the examining division | 29.03.2021 | Despatch of a communication from the examining division (Time limit: M04) | 10.08.2021 | Application deemed to be withdrawn, date of legal effect [2022/01] | 31.08.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2022/01] | Fees paid | Renewal fee | 25.05.2018 | Renewal fee patent year 03 | 29.05.2019 | Renewal fee patent year 04 | 29.05.2020 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.05.2021 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]CN100490787C (BAOAN WANG [CN]) [X] 1,4-7 * the whole document * [Y] 1-7; | [Y] - Jw Liu ET AL, "Protective effect of Yixinshu capsule on myocardial ischemia reperfusion injury in rats", (20130101), URL: http://www.ncbi.nlm.nih.gov/pubmed/24066601, (20181026), XP055519518 [Y] 1-7 * abstract * | International search | [A]JPH0789863 (MORISHITA PHARMA, et al) [A] 1-7* , abstract *; | [Y]CN1634206 (WANG BAOAN [CN]) [Y] 1-7 * , claims 1-2 *; | [Y]CN104483408 (WANG BAOAN) [Y] 1-7 * , description, paragraphs 002-003 *; | [PX]CN104825782 (SHAANXI MOMENTUM PHARMACEUTICAL CO LTD) [PX] 1-7 * , claims 1-7 *; | [Y] - YUAN, SIWEN;, "Observation on Sixty Cases of Rapid Arrhythmia Treated with Xinsuning Capsules", JOURNAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, (20000731), vol. 24, no. 4, pages 290 - 293, XP 055497779 [Y] 1-7 | [Y] - LIN, LEI et al., "26 Cases of Frequent Ventricular Procontraction Treated with Xinsuning Capsules", PEOPLE'S MILITARY SURGEON, (20110601), vol. 54, no. 6, page 512, XP009507368 [Y] 1-7 |